Okava Pharmaceuticals in San Francisco CA launched MEOW-1, a clinical study that will utilize tiny, under-the skin implants to release a GLP-1 medication drug into 50 cats for a period of six months or so.
A cat on weight loss drugs? Pharmaceutical company Okava Pharmaceuticals is launching a clinical trial into weight loss drugs for cats, according to multiple reports, in the first trial of its kind. Read more: https://bit.ly/3KJYHWk
-- ABC News 4 - WCIV (@abcnews4.com) Dec 5, 2025 at 10:30 PM
[image or embed]
This implant treatment allegedly has the potential to enhance cats' quality of life and promote healthy aging. Roughly six in ten American cats are overweight. The side effects of this drug on our feline friends are not known at this time.
Sources: YouTube: Ozympec for Kitties ; https://www.okava.com
"Huh? Me? No, I'm good. But thanks for asking. Zzzzz...."
